OTCMKTS:TEAR TearLab (TEAR) Stock Price, News & Analysis $0.06 0.00 (-1.86%) As of 07/9/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About TearLab Stock (OTCMKTS:TEAR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get TearLab alerts:Sign Up Key Stats Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.0652-Week Range$0.02▼$0.22Volume20,200 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview TearLab Corporation (OTCMKTS:TEAR) is a medical diagnostics company focused on advancing ocular health through innovative tear osmolarity testing. The company develops and commercializes point-of-care systems that measure tear osmolarity—a key biomarker for diagnosing and managing dry eye disease. By leveraging microfluidics and lab-quality analytical methods in a compact desktop platform, TearLab aims to bring objective, quantitative tear analysis to eye care practices worldwide. Since its founding in 2004, TearLab has introduced the TearLab Osmolarity System and single-use Test Cards, which enable clinicians to obtain accurate osmolarity measurements in under thirty seconds using only a nanoliter tear sample. The system has received regulatory clearances in the United States, Europe and other international jurisdictions, and supports evidence-based treatment decisions in ophthalmology and optometry. TearLab continues to invest in research and development, collaborating with academic institutions and industry partners to refine measurement technology and explore additional tear-based biomarkers. Headquartered in San Diego, California, TearLab serves a global customer base through direct sales and a network of distributors covering North America, Europe, Asia Pacific and Latin America. The company’s solutions are employed in a variety of clinical settings, including private eye care practices, hospital ophthalmology departments and dry eye research centers. TearLab’s leadership team is led by President and CEO John Tucker, whose background in medical device commercialization and diagnostics has guided the company through product launches, regulatory milestones and expansion of its global footprint.AI Generated. May Contain Errors. Read More Receive TEAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter. Email Address TEAR Stock News HeadlinesHarrow Announces New Appointments to its Board of DirectorsJanuary 29, 2024 | finance.yahoo.comSTRATA Skin Science Announces Leadership ChangeOctober 30, 2023 | benzinga.comForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.July 12 at 2:00 AM | Brownstone Research (Ad)Ocular Therapeutix™ Announces Appointment of New Board MemberJuly 12, 2023 | finance.yahoo.comOcular Allergy Diagnostic Systems Market Size 2023 with End-user Industries, Segments Covered in the ReportJanuary 15, 2023 | marketwatch.comHousing Authority officials want more police help at East AcresSeptember 9, 2022 | yahoo.comLawrence schools on 'good footing' financiallySeptember 9, 2022 | yahoo.comPathway Makes Four Senior PromotionsSeptember 9, 2022 | nz.finance.yahoo.comSee More Headlines TEAR Stock Analysis - Frequently Asked Questions How have TEAR shares performed this year? TearLab's stock was trading at $0.0579 on January 1st, 2025. Since then, TEAR shares have increased by 0.0% and is now trading at $0.0579. How were TearLab's earnings last quarter? TearLab Corporation (OTCMKTS:TEAR) issued its quarterly earnings data on Thursday, August, 8th. The medical research company reported ($0.10) earnings per share for the quarter. The medical research company had revenue of $5.85 million for the quarter. When did TearLab's stock split? Shares of TearLab reverse split on the morning of Friday, February 24th 2017.The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 23rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of TearLab? Shares of TEAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TearLab own? Based on aggregate information from My MarketBeat watchlists, some other companies that TearLab investors own include Vertex Energy (VTNR), Protalix BioTherapeutics (PLX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Immunomedics (IMMU), CorMedix (CRMD) and Rigel Pharmaceuticals (RIGL). Company Calendar Last Earnings8/08/2019Today7/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolOTCMKTS:TEAR Previous SymbolNASDAQ:TEAR CIK1299139 Webwww.tearlab.com Phone858-455-6006Fax858-812-0540Employees34Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (OTCMKTS:TEAR) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TearLab Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share TearLab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.